Amrubicin Study for Elderly Patients With Extensive-disease Small-cell Lung Cancer (ED-SCLC)
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy and toxicity of amrubicin with
carboplatin plus etoposide in elderly patients with extensive-disease small-cell lung cancer.